Terms: = Liver cancer AND TPR, P12270, 7175 AND Diagnosis
5 results:
1. The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States.
Tayob N; Kanwal F; Alsarraj A; Hernaez R; El-Serag HB
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):415-423.e4. PubMed ID: 35124267
[TBL] [Abstract] [Full Text] [Related]
2. Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma.
Mehta AS; Lau DT; Wang M; Aslam A; Nasir B; Javaid A; Poongkunran M; Block TM
PLoS One; 2018; 13(8):e0203149. PubMed ID: 30169533
[TBL] [Abstract] [Full Text] [Related]
3. Identification of personalized dysregulated pathways in hepatocellular carcinoma.
Li H; Jiang X; Zhu S; Sui L
Pathol Res Pract; 2017 Apr; 213(4):327-332. PubMed ID: 28215647
[TBL] [Abstract] [Full Text] [Related]
4. Fine needle aspirating and cutting is superior to Tru-cut core needle in liver biopsy.
Li GP; Gong GQ; Wang XL; Chen Y; Cheng JM; Li CY
Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):508-11. PubMed ID: 24103281
[TBL] [Abstract] [Full Text] [Related]
5. Use of a variety of biological parameters in distinguishing cirrhotic from malignant ascites.
Alexandrakis MG; Moschandrea J; Kyriakou DS; Alexandraki R; Kouroumalis E
Int J Biol Markers; 2001; 16(1):45-9. PubMed ID: 11288954
[TBL] [Abstract] [Full Text] [Related]
